Winnepenninckx’s career has included responsibility for commercial operations across Europe, Africa, Australia and New Zealand.
The transaction includes the first and only European commercial vaccine against swine dysentery caused by Brachyspira H.
Cave Animal Health is currently ranked as the world’s fifth-largest animal health company.
The Hub will serve as a collaborative platform for scientists, researchers, and industry stakeholders to drive research, innovation, and capacity-building in animal health.
Ceva’s management team has increased its shareholding and retained the majority of voting rights, ensuring the company remains independent.